Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

IMPORTANCE: Patients with type 2 diabetes are at high risk of cardiovascular disease (CVD) in part owing to hypertriglyceridemia and low high-density lipoprotein cholesterol. It is unknown whether adding triglyceride-lowering treatment to statin reduces this risk. OBJECTIVE: To determine whether fen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Cardiol
Autori principali: Elam, Marshall B., Ginsberg, Henry N., Lovato, Laura C., Corson, Marshall, Largay, Joseph, Leiter, Lawrence A., Lopez, Carlos, O’Connor, Patrick J., Sweeney, Mary Ellen, Weiss, Daniel, Friedewald, William T., Buse, John B., Gerstein, Hertzel C., Probstfield, Jeffrey, Grimm, Richard, Ismail-Beigi, Faramarz, Goff, David C., Fleg, Jerome L., Rosenberg, Yves, Byington, Robert P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2016
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5470410/
https://ncbi.nlm.nih.gov/pubmed/28030716
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2016.4828
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi